Patent 9371271 was granted and assigned to NOF (defunct) on June, 2016 by the United States Patent and Trademark Office.
In production of a cationic lipid having at least one methylene group sandwiched between adjacent two cis form double bonds in the molecule, isomerization from a cis form to a trans form is suppressed.